Strain Information | |
---|---|
Image | |
BRC No. | RBRC10368 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | B6.129P2-Pin1<tm1Tuc> |
Former Common name | Pin1-KO mouse |
H-2 Haplotype | |
ES Cell line | E14 [129P2/OlaHsd] |
Background strain | C57BL/6JJcl |
Appearance | |
Strain development | Developed by Takashi Uchida, Graduate School and Faculty of Agricultural Science, Tohoku University. E14 ES derived from 129P2/OlaHsd cells were used, and then mice were backcrossed to C57BL/6J over 13 generations. |
Strain description | Pin1, protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1 knockout mice. A neomycin resistance cassette replaced exons 1-4. |
Colony maintenance | |
References | Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Liou Y C, Ryo A, Huang H K, Lu P J, Bronson R, Fujimori F, Uchida T, Hunter T, Lu K P Proc. Natl. Acad. Sci. USA, 99, 1335-1340 (2002). 11805292Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Fujimori F, Takahashi K, Uchida C, Uchida T Biochem. Biophys. Res. Commun., 265, 658-663 (1999). 10600477 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Pin1 | peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1 | 9 | Pin1 | targeted mutation 1, Takafumi | |||
loxP | phage P1 loxP | 9 | loxP | ||||
loxP | phage P1 loxP | 9 | loxP | ||||
neo | neomycin resistance gene (E. coli) | 9 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 13 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Phage P1 loxP sites, mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, mouse Pin1 genomic DNA |
Research application | Cancer Research Cardiovascular Research Cre/loxP system Diabetes and Obesity Research Immunology and Inflammation Research covid19_progression |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Biochem. Biophys. Res. Commun., 265, 658-663 (1999).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Takafumi Uchida (Tohoku University) |
Strain Status | Frozen sperm |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |